de Fremont J F, Schmit J L, Thomas D, Coevoet B, Eb F, Laurence G, Orfila J, Fournier A
Pathol Biol (Paris). 1982 Jun;30(6 Pt 2):581-4.
Thirty patients were treated with continuous ambulatory peritoneal dialysis during 313 patients months. 26 episodes of peritonitis defined by a cloudy dialysate with more than 100 cells/mm1 and more than 50 p. cent of polynuclear were observed. The organisms initially responsible were Gram-positive in 11 cases (6 Staphylococcus aureus, 1 Staphylococcus albus, 4 Streptococcus viridans), a gram negative in 3 cases (1 Klebsiella, 1 serratio, one unidentified), a Candida in 2 cases. In 10 cases, the culture was negative, Initial treatment was peritoneal lavage (40 l/day) with in situ antibiotics: in the absence of Candida, the association sulfamethoxazole (SMZ) (80 mg/l) and trimethoprim (TMP) (16 mg/l) was used; when Candida was present amphotericin B (5 mg/l) was used. The association SMZ + TMP led to cure of PT in 17 cases, in 7 +/- 4 days. In 5 cases, this initial treatment was changed at the 48th hour because of initial resistance in one case or secondary resistance of Candida surinfection (2 cases). Candida surinfection occurred later in 2 other cases. For these 6 primary or secondary Candida peritonitis, the catheter was changed within 48 hours. Nevertheless, death occurred in 3 cases and cure was obtained after 51 +/- 11 days in the 3 other cases.
30例患者在313个患者月期间接受持续非卧床腹膜透析治疗。观察到26例腹膜炎发作,表现为透析液浑浊,细胞数超过100/mm³,多核细胞超过50%。最初致病的微生物中,革兰氏阳性菌11例(6例金黄色葡萄球菌、1例白色葡萄球菌、4例草绿色链球菌),革兰氏阴性菌3例(1例克雷伯菌、1例沙雷菌、1例未鉴定菌),念珠菌2例。10例培养结果为阴性。初始治疗为腹膜灌洗(40升/天)并局部使用抗生素:无念珠菌感染时,使用磺胺甲恶唑(SMZ)(80毫克/升)和甲氧苄啶(TMP)(16毫克/升)联合用药;有念珠菌感染时,使用两性霉素B(5毫克/升)。SMZ + TMP联合用药使17例腹膜炎在7±4天内治愈。5例中,因1例初始耐药或念珠菌二重感染继发耐药(2例),在48小时时更改了初始治疗方案。另外2例后来发生念珠菌二重感染。对于这6例原发性或继发性念珠菌性腹膜炎,在48小时内更换了导管。尽管如此,3例死亡,另外3例在51±11天后治愈。
1)SMZ + TMP初始治疗在大多数情况下(73%)似乎相当有效。2)念珠菌二重感染的严重性和高发生率表明其系统性预防可能是合适的。